Nanotein Technologies
Blood & Organ Banks · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2950 San Pablo Ave, Berkeley, California...Phone Number
(866) 828-2355Website
www.nanoteintech.comRevenue
<$5 MillionIndustry
About Nanotein Technologies
Nanotein Technologies specializes in biomanufacturing reagents that enhance the activation and expansion of T cells, particularly for CAR-T cell therapies. Their proprietary technology produces clinically potent CAR-T cells that are reported to have increased efficacy and longevity compared to competitor products. The company aims to address manufacturing challenges in the CAR-T industry by improving the quality and quantity of T cells, thereby facilitating the development of more effective cancer therapies. Their target clients include biotech companies and research institutions focused on advancing cell therapy manufacturing.Explore more
Nanotein Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Nanotein Technologies
Compare insights from companies similar to Nanotein Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Nanotein Technologies Tech Stack
A closer look at the technologies used by Nanotein Technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nanotein Technologies
Sign Up For FreeTo access detailed company insights
Nanotein Technologies specializes in biomanufacturing reagents that enhance the activation and expansion of T cells, particularly for CAR-T cell therapies. Their proprietary technology produces clinically potent CAR-T cells that are reported to have increased efficacy and longevity compared to competitor products. The company aims to address manufa... Read More
